Modulation of fibronectin synthesis by cancer cell-fibroblast interaction

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Cancer cells interact with the tumor microenvironment, influencing extracellular matrix (ECM) production.
• Fibronectin (FN) is a key ECM protein involved in cell adhesion and migration.
• Alternative splicing of FN, particularly at the EDA region, can alter its function.

Purpose of the Study:

• To investigate the effect of rectal adenocarcinoma cell-conditioned medium (CM) on fibroblast fibronectin (FN) production and splicing.
• To determine the role of transforming growth factor-beta (TGF-β) in mediating these effects.
• To explore the implications for cancer cell adhesion and invasion.

Main Methods:

• Incubation of human fibroblasts with CM from RCM-1 rectal cancer cells.
• Analysis of cellular (c-) and plasma (p-) FN production.
• Assessment of FN alternative splicing at the EDA region using RT-PCR.
• Inhibition studies using anti-TGF-β antibodies.
• Detection of TGF-β production by RCM-1 cells via immunoblotting and RT-PCR.

Main Results:

• RCM-1 CM stimulated both c-FN and p-FN production by fibroblasts.
• CM treatment increased the expression of EDA-containing (+) FN mRNA.
• The stimulatory effect of CM on FN splicing was significantly inhibited by anti-TGF-β antibodies.
• RCM-1 cells produced TGF-β.
• RCM-1 cells showed more efficient adhesion to EDA-containing cFN compared to pFN.

Conclusions:

• Cancer cell-fibroblast interactions, predominantly mediated by TGF-β, stimulate FN synthesis and EDA inclusion in fibroblasts.
• Enhanced expression of EDA-containing FN may facilitate cancer cell adhesion.
• The cancer stroma, modulated by cancer cell-fibroblast crosstalk, could play a role in promoting cancer invasion.